<div style="width: 100%; height: 500px; margin: 20px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; position: relative; z-index: 1;">
    <iframe 
        src="https://s.tradingview.com/widgetembed/?symbol=LLY&interval=D&theme=Light&style=1&locale=en&toolbarbg=f1f3f6&hideideas=1&studies=%5B%22MASimple%40tv-basicstudies%22%2C%20%22MACD%40tv-basicstudies%22%5D" 
        style="width: 100%; height: 100%; border: 0; display: block;" 
        scrolling="no" 
        allowtransparency="true" 
        frameborder="0">
    </iframe>
</div>

📊 TECHNICAL DEEP DIVE (Multi-Timeframe Analysis) A. TREND STRUCTURE (The "Big Picture") - MA System: On the weekly chart, the trend is bullish with the price above the Weekly MA20. However, on the daily chart, the trend turns bearish as the price is below the Daily MA20 (1070.58), indicating a potential pullback or correction in the short term. - Bollinger Bands: The daily Bollinger Band width is 6.22, with the price near the lower band (1037.27), suggesting weakness. The band width is not significantly expanding, which might indicate a controlled volatility environment. B. MOMENTUM & MONEY FLOW (The "Engine") - MACD: The weekly MACD histogram is positive (11.129), indicating strong momentum. However, the daily MACD histogram is negative (-6.114), suggesting fading momentum in the short term. There's a potential for a bearish divergence if the weekly momentum starts to weaken. - RSI & KDJ: The daily RSI(14) is 44.63, which is neutral, and the KDJ (J) is -16.05, indicating a trend reversal signal. - OBV (Volume): Not explicitly provided, but given the context, it's crucial to monitor volume to confirm any price movements. - ATR (Volatility): The ATR (31.68) suggests moderate volatility, which could impact stop-loss levels and option strike selections. C. VERDICT: The technical outlook for Eli Lilly suggests a bullish long-term trend but a bearish short-term trend, indicating a potential pullback or consolidation phase. 🎯 QUANT SCORE (2-4 Weeks View) [LONG SCORE: 40] [SHORT SCORE: 60] Given the bearish daily trend and the weakening momentum indicators, the short score is higher, reflecting the potential for a near-term downturn. 🚀 STRATEGY & RISK MANAGEMENT - Action: Enter a short position or wait for a clearer bullish reversal signal. - Levels: Support near the lower Bollinger Band (1037.27) and resistance at the Daily MA20 (1070.58). - Option Play: Consider selling spreads or buying put options if volatility (IV) is high, leveraging the current bearish momentum. 🧐 ASSET PROFILE (Fundamental Context) - Identity: Eli Lilly (LLY) is a pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products worldwide. Its business model includes a diverse portfolio of products for various diseases, including diabetes, cancer, and immunology. - Status/Holdings: As a major player in the pharmaceutical industry, Eli Lilly has a strong portfolio of drugs and a significant presence in the global market. Its recent profitability has been affected by factors like drug pricing pressures and research & development expenses. The net income growth has seen fluctuations, reflecting the competitive and regulatory challenges in the pharma sector. - PE/Valuation Status: With a current price of 1032.92, and without the explicit PE ratio provided, it's challenging to determine if Eli Lilly is overvalued or undervalued directly. However, given the recent bearish trend in the daily chart, one might argue that the stock could be entering a period where it might be considered relatively cheaper compared to its recent highs, depending on the industry averages and the company's financial performance.